Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Feb;25(2):157–163. doi: 10.1111/j.1365-2125.1988.tb03286.x

The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.

K A Miszkiel 1, R Beasley 1, P Rafferty 1, S T Holgate 1
PMCID: PMC1386469  PMID: 2451929

Abstract

1. To investigate the possibility that benzalkonium chloride-induced bronchoconstriction results from the endogenous release of histamine, we examined the effect of the selective histamine antagonists terfenadine and astemizole, on the airways response to inhaled benzalkonium chloride and histamine in 12 asthmatic subjects. 2. Double-blind concentration- and time-course studies were undertaken, 3 h after treatment with terfenadine or matched placebo. 3. Benzalkonium chloride and histamine caused concentration-related falls in FEV1 in all subjects with benzalkonium chloride being 7.4 times less potent as a bronchoconstrictor agonist than histamine. Terfenadine displaced to the right the benzalkonium chloride and histamine concentration-response curves by 3.7 and 111 fold respectively. Terfenadine attenuated the initial (5 min) bronchoconstrictor response to benzalkonium chloride by 40%. However, over the whole 45 min period, the response was reduced by only 13% compared with 86% inhibition of the response to histamine. 4. In an open study, eight of the 12 subjects undertook a time course study with inhaled benzalkonium chloride after pretreatment with the chemically unrelated histamine antagonist astemizole. Astemizole inhibited benzalkonium chloride-induced bronchoconstriction to an almost identical degree as that achieved with terfenadine. 5. We conclude that the initial bronchoconstrictor effect of benzalkonium chloride is due, in part, to histamine release. However, the majority of the adverse effect relates to other, as yet unrecognised effects of this bacteriocidal substance.

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley C. R., Rafferty P., Holgate S. T. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. Br Med J (Clin Res Ed) 1987 May 9;294(6581):1197–1198. doi: 10.1136/bmj.294.6581.1197-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beasley C. R., Robinson C., Featherstone R. L., Varley J. G., Hardy C. C., Church M. K., Holgate S. T. 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest. 1987 Mar;79(3):978–983. doi: 10.1172/JCI112909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bisgaard H., Groth S., Madsen F. Bronchial hyperreactivity to leucotriene D4 and histamine in exogenous asthma. Br Med J (Clin Res Ed) 1985 May 18;290(6480):1468–1471. doi: 10.1136/bmj.290.6480.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  5. Chung K. F., Morgan B., Keyes S. J., Snashall P. D. Histamine dose-response relationships in normal and asthmatic subjects. The importance of starting airway caliber. Am Rev Respir Dis. 1982 Nov;126(5):849–854. doi: 10.1164/arrd.1982.126.5.849. [DOI] [PubMed] [Google Scholar]
  6. Church M. K., Pao G. J., Holgate S. T. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol. 1982 Nov;129(5):2116–2121. [PubMed] [Google Scholar]
  7. Clark R. J. Exacerbation of asthma after nebulised beclomethasone diproprionate. Lancet. 1986 Sep 6;2(8506):574–575. doi: 10.1016/s0140-6736(86)90140-6. [DOI] [PubMed] [Google Scholar]
  8. Cockcroft D. W., Berscheid B. A. Effect of pH on bronchial response to inhaled histamine. Thorax. 1982 Feb;37(2):133–136. doi: 10.1136/thx.37.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coleman J. W., Holgate S. T., Church M. K., Godfrey R. C. Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen. Biochem J. 1981 Sep 15;198(3):615–619. doi: 10.1042/bj1980615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Connolly C. K. Adverse reaction to ipratropium bromide. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):934–935. doi: 10.1136/bmj.285.6346.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Connolly C. K. Adverse reaction to ipratropium bromide. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):934–935. doi: 10.1136/bmj.285.6346.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Holgate S. T., Burns G. B., Robinson C., Church M. K. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol. 1984 Oct;133(4):2138–2144. [PubMed] [Google Scholar]
  13. O'Callaghan C., Milner A. D., Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986 Dec 20;2(8521-22):1424–1425. doi: 10.1016/s0140-6736(86)92735-2. [DOI] [PubMed] [Google Scholar]
  14. Omini C., Brunelli G., Daffonchio L., Mapp C., Fabbri L., Berti F. Prostaglandin D2 (PGD2) potentiates cholinergic responsiveness in guinea-pig trachea. J Auton Pharmacol. 1986 Sep;6(3):181–186. doi: 10.1111/j.1474-8673.1986.tb00643.x. [DOI] [PubMed] [Google Scholar]
  15. Patel K. R., Tullett W. M. Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) 1983 Apr 23;286(6374):1318–1318. doi: 10.1136/bmj.286.6374.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Prendiville A., Green S., Silverman M. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax. 1987 Feb;42(2):86–91. doi: 10.1136/thx.42.2.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Read G. W., Kiefer E. F. Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines. J Pharmacol Exp Ther. 1979 Dec;211(3):711–715. [PubMed] [Google Scholar]
  18. Widdicombe J. The neural reflexes in the airways. Eur J Respir Dis Suppl. 1986;144:1–33. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES